On October 15, 2024, Linda Llewelyn, Chief People Officer of Health Catalyst Inc (HCAT, Financial), sold 1,324 shares of the company. The transaction was reported in a recent SEC Filing. Following this sale, the insider now owns 114,275 shares of Health Catalyst Inc.
Health Catalyst Inc is a provider of data and analytics technology and services to healthcare organizations. The company's solutions include a cloud-based data platform, analytics software, and professional services that are geared towards improving clinical, financial, and operational outcomes.
Over the past year, Linda Llewelyn has sold a total of 20,154 shares and has not purchased any shares. This recent transaction is part of a broader trend where Health Catalyst Inc has seen 24 insider sells and only 1 insider buy over the past year.
Shares of Health Catalyst Inc were trading at $8.16 on the day of the sale. The company has a market cap of approximately $523.071 million. According to the GF Value, the intrinsic value of the stock is estimated at $11.71, indicating that the stock is modestly undervalued with a price-to-GF-Value ratio of 0.7.
The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company’s past returns and growth, and future business performance estimates from Morningstar analysts.
This insider sale might be of interest to investors tracking insider behaviors and evaluating the valuation and investment potential of Health Catalyst Inc based on current market data and intrinsic value assessments.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
